Vaishali Pharma (NSE:VAISHALI) LT-Debt-to-Total-Asset: 0.04 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VAISHALI Vaishali Pharma Ltd NSE:VAISHALI
52 GF Score
Price ₹7.99
View Full Analysis

What is Vaishali Pharma LT-Debt-to-Total-Asset?

Vaishali Pharma NSE:VAISHALI +0.50% 52 LT-Debt-to-Total-Asset is 0.04 as of Mar. 2025. GuruFocus rates NSE:VAISHALI with a GF Score™ of 52/100.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Vaishali Pharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2025 was 0.04.

Vaishali Pharma's long-term debt to total assets ratio declined from Mar. 2024 (0.05) to Mar. 2025 (0.04). It may suggest that Vaishali Pharma is progressively becoming less dependent on debt to grow their business.

Vaishali Pharma  (NSE:VAISHALI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Vaishali Pharma LT-Debt-to-Total-Asset Related Terms

Vaishali Pharma LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Vaishali Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaishali Pharma LT-Debt-to-Total-Asset Chart

Vaishali Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.04 0.08 0.05 0.04

Vaishali Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.00 0.03 0.00 0.04
NSE:VAISHALI
52GF Score
Vaishali Pharma Ltd NSE:VAISHALI
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaishali Pharma LT-Debt-to-Total-Asset Calculation

Vaishali Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (A: Mar. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2025 )/Total Assets (A: Mar. 2025 )
=46.193/1098.449
=0.04

Vaishali Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (Q: Mar. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2025 )/Total Assets (Q: Mar. 2025 )
=46.193/1098.449
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.04 mean?
Vaishali Pharma (NSE:VAISHALI) has a LT-Debt-to-Total-Asset of 0.04 as of Mar. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Vaishali Pharma and its competitors.
Is Vaishali Pharma's LT-Debt-to-Total-Asset too high?
Vaishali Pharma's current LT-Debt-to-Total-Asset is 0.04. Overall, Vaishali Pharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vaishali Pharma's LT-Debt-to-Total-Asset compare to ZTS?
Vaishali Pharma's LT-Debt-to-Total-Asset of 0.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Vaishali Pharma and its competitors. Vaishali Pharma's current LT-Debt-to-Total-Asset is 0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaishali Pharma stock overvalued right now?
Vaishali Pharma (NSE:VAISHALI) has a current LT-Debt-to-Total-Asset of 0.04. The current LT-Debt-to-Total-Asset is 0.04. Vaishali Pharma's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Vaishali Pharma (NSE:VAISHALI), the current LT-Debt-to-Total-Asset is 0.04 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaishali Pharma Business Description

Address R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092
Vaishali Pharma Ltd is a pharmaceutical company. The Company is engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients.
52GF Score

Get the complete analysis for NSE:VAISHALI

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.99
Price